Susquehanna International Group’s Blueprint Medicines BPMC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-184,115
| Closed | -$23.6M | – | 12438 |
|
|
2025
Q2 | $23.6M | Sell |
184,115
-228,425
| -55% | -$23.7M | ﹤0.01% | 1832 |
|
|
2025
Q1 | $36.5M | Buy |
412,540
+276,329
| +203% | +$27M | 0.01% | 1236 |
|
|
2024
Q4 | $11.9M | Buy |
136,211
+12,394
| +10% | +$1.14M | ﹤0.01% | 2449 |
|
|
2024
Q3 | $11.5M | Buy |
123,817
+62,236
| +101% | +$6.18M | ﹤0.01% | 2436 |
|
|
2024
Q2 | $6.64M | Sell |
61,581
-67,916
| -52% | -$6.8M | ﹤0.01% | 3009 |
|
|
2024
Q1 | $12.3M | Buy |
129,497
+40,254
| +45% | +$3.45M | ﹤0.01% | 2345 |
|
|
2023
Q4 | $8.23M | Sell |
89,243
-226,338
| -72% | -$14.7M | ﹤0.01% | 2908 |
|
|
2023
Q3 | $15.8M | Buy |
315,581
+177,592
| +129% | +$9.49M | ﹤0.01% | 2013 |
|
|
2023
Q2 | $8.72M | Sell |
137,989
-21,443
| -13% | -$1.17M | ﹤0.01% | 2680 |
|
|
2023
Q1 | $7.17M | Buy |
159,432
+98,055
| +160% | +$4.42M | ﹤0.01% | 2924 |
|
|
2022
Q4 | $2.69M | Buy |
61,377
+12,909
| +27% | +$619K | ﹤0.01% | 4186 |
|
|
2022
Q3 | $3.19M | Buy |
48,468
+16,979
| +54% | +$1.09M | ﹤0.01% | 3954 |
|
|
2022
Q2 | $1.59M | Sell |
31,489
-39,019
| -55% | -$2.29M | ﹤0.01% | 5393 |
|
|
2022
Q1 | $4.5M | Buy |
70,508
+35,704
| +103% | +$2.56M | ﹤0.01% | 3810 |
|
|
2021
Q4 | $3.73M | Buy |
34,804
+2,784
| +9% | +$291K | ﹤0.01% | 4264 |
|
|
2021
Q3 | $3.29M | Sell |
32,020
-6,255
| -16% | -$582K | ﹤0.01% | 4765 |
|
|
2021
Q2 | $3.37M | Buy |
38,275
+27,466
| +254% | +$2.52M | ﹤0.01% | 4777 |
|
|
2021
Q1 | $1.05M | Sell |
10,809
-5,904
| -35% | -$589K | ﹤0.01% | 7609 |
|
|
2020
Q4 | $1.87M | Sell |
16,713
-855
| -5% | -$90.1K | ﹤0.01% | 5234 |
|
|
2020
Q3 | $1.63M | Sell |
17,568
-21,125
| -55% | -$1.63M | ﹤0.01% | 5009 |
|
|
2020
Q2 | $3.02M | Sell |
38,693
-190,367
| -83% | -$12.9M | ﹤0.01% | 3796 |
|
|
2020
Q1 | $13.4M | Buy |
229,060
+168,578
| +279% | +$10.8M | ﹤0.01% | 1469 |
|
|
2019
Q4 | $4.84M | Buy |
60,482
+26,867
| +80% | +$2.01M | ﹤0.01% | 3007 |
|
|
2019
Q3 | $2.47M | Buy |
33,615
+1,382
| +4% | +$119K | ﹤0.01% | 3806 |
|
|
2019
Q2 | $3.04M | Buy |
32,233
+23,915
| +288% | +$1.97M | ﹤0.01% | 3422 |
|
|
2019
Q1 | $666K | Buy |
+8,318
| New | +$615K | ﹤0.01% | 5754 |
|
|
2018
Q3 | – | Sell |
-94,715
| Closed | -$6.58M | – | 9230 |
|
|
2018
Q2 | $6.01M | Buy |
+94,715
| New | +$7.54M | ﹤0.01% | 2499 |
|
|
2018
Q1 | – | Sell |
-17,966
| Closed | -$1.55M | – | 9327 |
|
|
2017
Q4 | $1.35M | Buy |
+17,966
| New | +$1.26M | ﹤0.01% | 4629 |
|
Other funds holding BPMC
IA
HNB
Susquehanna International Group's BPMC Position: Q3 2025 in Review
Susquehanna International Group sold out of Blueprint Medicines (BPMC) in Q3 2025, closing a stake of 184,115 shares — an estimated $23.6M sold.
Susquehanna International Group first reported a position in BPMC in Q4 2017 and held it in 28 quarters. The position peaked at $36.5M in Q1 2025. 5 funds tracked by Wall St. Rank hold BPMC as of Q3 2025.
- Susquehanna International Group reported no remaining Blueprint Medicines position as of Q3 2025 after selling out during the quarter.
- Susquehanna International Group sold 184,115 Blueprint Medicines shares in Q3 2025, an estimated $23.6M.
- Susquehanna International Group first reported a position in Blueprint Medicines in Q4 2017 and held it in 28 quarters.
- Susquehanna International Group's Blueprint Medicines position peaked at $36.5M in Q1 2025.
- 5 funds tracked by Wall St. Rank held Blueprint Medicines as of Q3 2025.
Based on Susquehanna International Group's 13F filing for Q3 2025, filed 14 Nov 2025.